Concepedia

Johannes Düll

JD

Statistics

Publications

5

Citations

236

H-Index

5

Active since

2016

Affiliations

Universitätsklinikum Würzburg(Current)

University of Würzburg

Comprehensive Cancer Center Mainfranken

Johannes Düll is an author at Universitätsklinikum Würzburg specializing in oncology, cancer immunotherapy, and cancer immunology.

Publications per year

2016–2023

5

Publications

5

Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression

Elias Jabbour, Johannes Düll, Musa Yılmaz et al. · American Journal of Hematology · 2017 · 83 citations · Full text

Medicine, Hematology, Oncology +14

A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement

Leo Rasche, Emmanuelle Ménoret, Valentina Dubljevic et al. · Clinical Cancer Research · 2016 · 57 citations · Full text

Medicine, Immunology, Oncology +16

Trade-off designs and comparative exergy evaluation of solid-oxide electrolyzer based power-to-methane plants

Ligang Wang, Johannes Düll, François Maréchal et al. · International Journal of Hydrogen Energy · 2018 · 45 citations · Full text

Engineering, Chemical Engineering, Mechanical Engineering +17

Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

Alexander M. Leipold, Rudolf A. Werner, Johannes Düll et al. · Leukemia · 2023 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma

Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava et al. · Cell Death Discovery · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 5